Orthofix initiated with a Hold at TD Cowen

TD Cowen initiated coverage of Orthofix (OFIX) with a Hold rating and $14 price target The company is affecting enterprise-wide change while driving improving profitability and cash flow, even though its top-line acceleration is less visible today and may not be until late 2026, the analyst tells investors in a research note. TD adds that it is unequivocally positive on to-date/ongoing efforts to reshape the investment story, noting however that for the shares to “work”, there needs to be evidence of accelerating sales.